PNPLA3 and metabolic dysfunction-associated steatotic liver disease: As regards the risks of fibrosis progression and of developing HCC, Singal et al. have clearly shown in their meta-analytic review that PNPLA3 rs738409 confers an increased risk of advanced fibrosis in individuals in whom chronic liver disease occurs as a result of varying etiologies, notably including NAFLD.